TGR5 modulators and methods of use thereof

Details for Australian Patent Application No. 2009276507 (hide)

Owner Intercept Pharmaceuticals, Inc.

Inventors Pellicciari, Roberto

Agent Cullens

Pub. Number AU-A-2009276507

PCT Pub. Number WO2010/014836

Priority 08013676.5 30.07.08 EP

Filing date 30 July 2009

Wipo publication date 4 February 2010

International Classifications

A61K 31/575 (2006.01) - substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07J 31/00 (2006.01) Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing sulfur

Event Publications

10 March 2011 PCT application entered the National Phase

  PCT publication WO2010/014836 Priority application(s): WO2010/014836

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009276512-Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof

2009276506-Delta6 desaturases and their use in making polyunsaturated fatty acids